Alterations in atrial perfusion during atrial fibrillation

Experimental Physiology

Volumn 99, Issue 10, 2014, Pages 1267-1272

  Pacchia, Christina F ^a   Dosdall, Derek J ^a   Ranjan, Ravi ^a   Dibella, Edward ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CORONARY ARTERY BLOOD FLOW; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM PERFUSION; HEART HEMODYNAMICS; HEART PERFUSION; HUMAN; PATHOPHYSIOLOGY; REVIEW; VASCULARIZATION; ANIMAL; ATRIAL FIBRILLATION; DISEASE COURSE; FIBROSIS; HEART MUSCLE ISCHEMIA; PATHOLOGY;

ANIMALS; ATRIAL FIBRILLATION; DISEASE PROGRESSION; FIBROSIS; HEART ATRIA; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 84908481863     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.080242     Document Type: Review

References (32)

1. Allessie M, Ausma J & Schotten U (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54, 230-246.
2. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M & Borgers M (1997). Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96, 3157-3163.
3. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ & Wolf PA (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271, 840-844.
4. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E & Nattel S (2003). Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 60, 315-325.
5. Davies MJ & Pomerance A (1972). Pathology of atrial fibrillation in man. Br Heart J 34, 520-525.
6. De Boer RA, Pinto YM & Van Veldhuisen DJ (2003). The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 10, 113-126.
7. Doughan AK, Harrison DG & Dikalov SI (2008). Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102, 488-496.
8. Friedman HS, O'Connor J, Kottmeier S, Shaughnessy E & McGuinn R (1987). The effects of atrial fibrillation on regional blood flow in the awake dog. Can J Cardiol 3, 240-245.
9. Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Röhl FW, Wolke C, Bergmann S, Bramlage P, Ravens U & Lendeckel U (2009). Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J 30, 1411-1420.
10. Goette A, Bukowska A, Lendeckel U, Erxleben M, Hammwöhner M, Strugala D, Pfeiffenberger J, Röhl FW, Huth C, Ebert MP, Klein HU & Röcken C (2008). Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 117, 732-742.
11. Goette A, Bukowska A, Lillig CH & Lendeckel U (2012). Oxidative stress and microcirculatory flow abnormalities in the ventricles during atrial fibrillation. Front Physiol 3, 236.
12. Heusch G, Baumgart D, Camici P, Chilian W, Gregorini L, Hess O, Indolfi C & Rimoldi O (2000). α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 101, 689-694.
13. Hiller KH, Roder F, Adami P, Voll S, Kowallik P, Haase A, Ertl G & Bauer WR (1997). Study of microcirculation by coloured microspheres and NMR-microscopy in isolated rat heart: effect of ischaemia, endothelin-1 and endothelin-1 antagonist BQ 610. J Mol Cell Cardiol 29, 3115-3122.
14. Kochiadakis GE, Skalidis EI, Kaleboubas MD, Igoumenidis NE, Hamilos MI, Parthenakis FI & Vardas PE (2001). Effect of acute atrial fibrillation on coronary circulation. Am J Cardiol 88, 1431-1433, A1438.
15. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM & Frye RL (1987). The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 317, 669-674.
16. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP & Schaper J (2002). Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54, 361-379.
17. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EV, Parker D, Macleod RS & Marrouche NF (2014). Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol 7, 23-30.
18. McHale PA, Rembert JC & Greenfield JC Jr (1983). Effect of atrial fibrillation on atrial blood flow in conscious dogs. Am J Cardiol 51, 1722-1727.
19. Mayyas F, Niebauer M, Zurick A, Barnard J, Gillinov AM, Chung MK & Van Wagoner DR (2010). Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 3, 369-379.
20. Neill WA, Sewell D, Gopal M, Oxendine J & Painter L (1980). Independent regulation of atrial coronary blood flow by atrial contraction rate in conscious dogs. Pflugers Arch 388, 193-195.
21. Neubauer S, Zimmermann S, Hirsch A, Pulzer F, Tian R, Bauer W, Bauer B & Ertl G (1991). Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol 23, 1397-1409.
22. Segerson NM, Sharma N, Smith ML, Wasmund SL, Kowal RC, Abedin M, MacGregor JF, Pai RK, Freedman RA, Klein RC, Wall TS, Stoddard G & Hamdan MH (2007). The effects of rate and irregularity on sympathetic nerve activity in human subjects. Heart Rhythm 4, 20-26.
23. Skinner NS Jr, Mitchell JH, Wallace AG & Sarnoff SJ (1964). Hemodynamic consequences of atrial fibrillation at constant ventricular rates. Am J Med 36, 342-350.
24. Thijssen VL, Ausma J & Borgers M (2001). Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res 52, 14-24.
25. Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ & Borgers M (2000). Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol 9, 17-28.
26. van Bragt KA, Nasrallah HM, Kuiper M, Luiken JJ, Schotten U & Verheule S (2014). Atrial supply-demand balance in healthy adult pigs: coronary blood flow, oxygen extraction, and lactate production during acute atrial fibrillation. Cardiovasc Res 101, 9-19.
27. Wasmund SL, Li JM, Page RL, Joglar JA, Kowal RC, Smith ML & Hamdan MH (2003). Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation 107, 2011-2015.
28. White CW, Holida MD & Marcus ML (1986). Effects of acute atrial fibrillation on the vasodilator reserve of the canine atrium. Cardiovasc Res 20, 683-689.
29. White CW, Kerber RE, Weiss HR & Marcus ML (1982). The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ Res 51, 205-215.
30. Wichmann J, Ertl G, Höhne W, Schweisfurth H, Wernze H & Kochsiek K (1983a). Alpha-receptor restriction of coronary blood flow during atrial fibrillation. Am J Cardiol 52, 887-892.
31. Wichmann J, Ertl G, Rudolph G & Kochsiek K (1983b). Effect of experimentally induced atrial fibrillation on coronary circulation in dogs. Basic Res Cardiol 78, 473-491.
32. Wijffels MC, Kirchhof CJ, Dorland R & Allessie MA (1995). Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92, 1954-1968.